Sign in with Google. Opens in new tab
bearish
Global Cord Blood (CO US): Gloomy Regulatory and Business Environment Explain Cheap Valuation
493 Views08 Apr 2022 15:47
SUMMARY
- Global Cord Blood (CO US) is facing regulatory and business environment uncertainty. China has not released any update on the new licenses of the country’s new cord blood bank.
- The company is seeing slower than expected business recovery and new subscriber addition is decelerating since Q1 FY22, mainly due to COVID-related restrictions.
- China’s birth rate dropped to a record low in 2021, thereby indicating sluggishness in the total addressable market of Global Cord.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Nikkei 225 Index Rebalance: Rohm (6963) To Replace NTT Data Group (9613)
- Krungthai Card (KTC TB): Buying Opportunity After Margin Call
- NVIDIA (NVDA US) At All-Time High Acquires CentML: Weekly Tactical Outlook (June 30 – July 4)
- Quiddity Leaderboard F100/F250 Sep25 Results: Methodology Change Could Result in a Surprise Addition
- StubWorld: Melco (200 HK) Needs To Fall
Top Unpaywalled Insights
More »- [IO Technicals 2025/26] Bearish Momentum Intensifies
- "The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
- The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- [IO Technicals 2025/25] Bearish Momentum Strengthens
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
x